Nebulized Albuterol for Congestive Heart Failure Exacerbation

This is a randomized trial of the use of Albuterol in the setting of acute decompensated Congestive Heart Failure with radiographic evidence of Cardiogenic Pulmonary Edema.

The objective is to carry out a randomized blinded placebo-controlled trial of inhaled Albuterol as an early therapy for patients with decompensated Congestive Heart Failure. Compared to placebo, inhaled Albuterol will improve oxygenation and decrease the need for non-invasive ventilation in patients with Cardiogenic Pulmonary Edema.

Inclusion Criteria:

• age 18-65 with shortness of breath and history of CHF
• pulmonary edema on chest xr

Exclusion Criteria:

• pregnancy
• clinical or ekg changes to suggest acute coronary syndrome
• history of copd or asthma
• history of albuterol on medication list